Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 15 | 2023 | 787 | 3.110 |
Why?
|
| Adipocytes | 5 | 2023 | 170 | 1.800 |
Why?
|
| Lysophospholipids | 8 | 2020 | 66 | 1.400 |
Why?
|
| Omentum | 3 | 2022 | 74 | 0.920 |
Why?
|
| Glycerol | 1 | 2023 | 35 | 0.830 |
Why?
|
| Cell Proliferation | 8 | 2022 | 1724 | 0.700 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2020 | 25 | 0.660 |
Why?
|
| Up-Regulation | 3 | 2020 | 729 | 0.560 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 28 | 0.540 |
Why?
|
| Glycolysis | 3 | 2018 | 184 | 0.510 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 622 | 0.500 |
Why?
|
| Transforming Growth Factor beta | 3 | 2012 | 330 | 0.490 |
Why?
|
| Hexokinase | 1 | 2015 | 22 | 0.490 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 167 | 0.470 |
Why?
|
| Tumor Microenvironment | 5 | 2023 | 521 | 0.440 |
Why?
|
| Cell Line, Tumor | 14 | 2020 | 2671 | 0.430 |
Why?
|
| Activins | 1 | 2012 | 26 | 0.390 |
Why?
|
| Lipogenesis | 1 | 2012 | 25 | 0.390 |
Why?
|
| Proteins | 1 | 2012 | 803 | 0.270 |
Why?
|
| Signal Transduction | 5 | 2015 | 3509 | 0.260 |
Why?
|
| Female | 17 | 2023 | 47894 | 0.250 |
Why?
|
| Receptors, Lysophosphatidic Acid | 4 | 2012 | 14 | 0.230 |
Why?
|
| Coculture Techniques | 3 | 2020 | 177 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 1311 | 0.230 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 2007 | 0.220 |
Why?
|
| Cell Movement | 5 | 2018 | 801 | 0.210 |
Why?
|
| Metformin | 2 | 2015 | 132 | 0.210 |
Why?
|
| Mice, Nude | 3 | 2020 | 827 | 0.210 |
Why?
|
| Neoplasm Proteins | 2 | 2020 | 547 | 0.200 |
Why?
|
| Phosphates | 1 | 2023 | 163 | 0.200 |
Why?
|
| Humans | 21 | 2023 | 92344 | 0.200 |
Why?
|
| Glucose | 2 | 2023 | 683 | 0.190 |
Why?
|
| Cell Survival | 3 | 2020 | 1008 | 0.190 |
Why?
|
| Fatty Acids | 1 | 2022 | 149 | 0.180 |
Why?
|
| Mice | 7 | 2020 | 12137 | 0.180 |
Why?
|
| Tumor Burden | 2 | 2020 | 314 | 0.170 |
Why?
|
| Protein Array Analysis | 1 | 2020 | 52 | 0.160 |
Why?
|
| Adipose Tissue | 1 | 2022 | 267 | 0.160 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 24 | 0.160 |
Why?
|
| Biphenyl Compounds | 1 | 2020 | 61 | 0.160 |
Why?
|
| Heterografts | 1 | 2020 | 107 | 0.160 |
Why?
|
| DNA Methylation | 2 | 2020 | 677 | 0.160 |
Why?
|
| Metabolomics | 1 | 2020 | 95 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 198 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 250 | 0.150 |
Why?
|
| Pyrazoles | 1 | 2020 | 154 | 0.150 |
Why?
|
| 5-Methylcytosine | 1 | 2020 | 117 | 0.150 |
Why?
|
| Carboplatin | 1 | 2020 | 321 | 0.150 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 213 | 0.150 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 1072 | 0.150 |
Why?
|
| Glycogen | 1 | 2018 | 60 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2020 | 524 | 0.150 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2018 | 37 | 0.140 |
Why?
|
| CD36 Antigens | 1 | 2018 | 15 | 0.140 |
Why?
|
| Proteomics | 1 | 2020 | 246 | 0.140 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 2369 | 0.140 |
Why?
|
| Animals | 9 | 2020 | 28056 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 707 | 0.130 |
Why?
|
| Paclitaxel | 2 | 2015 | 495 | 0.130 |
Why?
|
| Microtubule Proteins | 1 | 2015 | 2 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 4 | 2012 | 972 | 0.120 |
Why?
|
| Cilia | 1 | 2015 | 29 | 0.120 |
Why?
|
| Fibroblasts | 2 | 2015 | 768 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 176 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2015 | 2097 | 0.100 |
Why?
|
| ErbB Receptors | 2 | 2020 | 498 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 139 | 0.100 |
Why?
|
| Follistatin-Related Proteins | 1 | 2012 | 11 | 0.100 |
Why?
|
| Smad Proteins | 1 | 2012 | 44 | 0.100 |
Why?
|
| Smad3 Protein | 1 | 2012 | 25 | 0.100 |
Why?
|
| Smad4 Protein | 1 | 2012 | 25 | 0.100 |
Why?
|
| Fatty Acid Synthases | 1 | 2012 | 9 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2012 | 6 | 0.100 |
Why?
|
| Data Mining | 1 | 2012 | 44 | 0.100 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 46 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2012 | 283 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1939 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 79 | 0.090 |
Why?
|
| Ligands | 1 | 2012 | 457 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 1164 | 0.090 |
Why?
|
| Models, Biological | 2 | 2015 | 1786 | 0.080 |
Why?
|
| Transcription Factor AP-1 | 1 | 2010 | 65 | 0.080 |
Why?
|
| Binding Sites | 1 | 2012 | 1131 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 146 | 0.080 |
Why?
|
| Sp1 Transcription Factor | 1 | 2009 | 23 | 0.080 |
Why?
|
| Receptors, Purinergic | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 99 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 168 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2008 | 284 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 411 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2015 | 794 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2010 | 468 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 200 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2020 | 87 | 0.060 |
Why?
|
| Chemotactic Factors | 1 | 2005 | 14 | 0.060 |
Why?
|
| S100 Proteins | 1 | 2005 | 53 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2012 | 562 | 0.050 |
Why?
|
| Disease Progression | 2 | 2018 | 1505 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 404 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2011 | 1140 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2014 | 313 | 0.050 |
Why?
|
| ADAM17 Protein | 1 | 2020 | 9 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 85 | 0.040 |
Why?
|
| Neoplasms | 1 | 2015 | 3124 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2020 | 273 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 888 | 0.040 |
Why?
|
| RNA, Messenger | 3 | 2012 | 2038 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2905 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 1191 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 3054 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2010 | 569 | 0.030 |
Why?
|
| Phenformin | 1 | 2015 | 5 | 0.030 |
Why?
|
| Tubulin Modulators | 1 | 2015 | 23 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2015 | 13 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 128 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 146 | 0.030 |
Why?
|
| Tubulin | 1 | 2015 | 60 | 0.030 |
Why?
|
| COS Cells | 1 | 2015 | 167 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 189 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1108 | 0.030 |
Why?
|
| Ascites | 1 | 2015 | 57 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 224 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2015 | 99 | 0.030 |
Why?
|
| Cricetinae | 1 | 2015 | 538 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 283 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 1805 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2015 | 431 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 1771 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2015 | 202 | 0.030 |
Why?
|
| Base Sequence | 2 | 2008 | 2319 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 360 | 0.020 |
Why?
|
| Response Elements | 1 | 2012 | 65 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2015 | 464 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 385 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2010 | 33 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 118 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 85 | 0.020 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2008 | 26 | 0.020 |
Why?
|
| ELAV Proteins | 1 | 2008 | 2 | 0.020 |
Why?
|
| ELAV-Like Protein 1 | 1 | 2008 | 3 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2008 | 36 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 295 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3375 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2008 | 63 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2008 | 73 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2008 | 88 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2008 | 104 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1745 | 0.020 |
Why?
|
| RNA Stability | 1 | 2008 | 92 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 281 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2008 | 211 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 698 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 542 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 298 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2008 | 163 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2008 | 117 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 364 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 354 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 1575 | 0.020 |
Why?
|
| S100 Calcium Binding Protein A6 | 1 | 2005 | 12 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 284 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2008 | 581 | 0.010 |
Why?
|
| Male | 2 | 2008 | 43928 | 0.010 |
Why?
|